295 related articles for article (PubMed ID: 25549232)
1. Advances in sickle cell therapies in the hydroxyurea era.
Field JJ; Nathan DG
Mol Med; 2014 Dec; 20 Suppl 1(Suppl 1):S37-42. PubMed ID: 25549232
[TBL] [Abstract][Full Text] [Related]
2. Advances in the Treatment of Sickle Cell Disease.
Kapoor S; Little JA; Pecker LH
Mayo Clin Proc; 2018 Dec; 93(12):1810-1824. PubMed ID: 30414734
[TBL] [Abstract][Full Text] [Related]
3. Treatment Options for Sickle Cell Disease.
Meier ER
Pediatr Clin North Am; 2018 Jun; 65(3):427-443. PubMed ID: 29803275
[TBL] [Abstract][Full Text] [Related]
4. Cellular therapy for sickle cell disease.
Abraham A; Jacobsohn DA; Bollard CM
Cytotherapy; 2016 Nov; 18(11):1360-1369. PubMed ID: 27421743
[TBL] [Abstract][Full Text] [Related]
5. [Advances in sickle cell disease treatments: Towards targeted therapies].
Arlet JB
Rev Med Interne; 2020 Feb; 41(2):73-77. PubMed ID: 31771774
[No Abstract] [Full Text] [Related]
6. Sickle cell disease: progress towards combination drug therapy.
Pace BS; Starlard-Davenport A; Kutlar A
Br J Haematol; 2021 Jul; 194(2):240-251. PubMed ID: 33471938
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic advances in sickle cell disease in the last decade.
Shet AS; Thein SL
Indian J Med Res; 2017 Jun; 145(6):708-712. PubMed ID: 29067969
[No Abstract] [Full Text] [Related]
8. Sickle Cell Disease: A Brief Update.
Azar S; Wong TE
Med Clin North Am; 2017 Mar; 101(2):375-393. PubMed ID: 28189177
[TBL] [Abstract][Full Text] [Related]
9. Hydroxyurea for children with sickle cell disease.
Heeney MM; Ware RE
Pediatr Clin North Am; 2008 Apr; 55(2):483-501, x. PubMed ID: 18381097
[TBL] [Abstract][Full Text] [Related]
10. Red Blood Cells as Therapeutic Target to Treat Sickle Cell Disease.
Bhatt S; Argueta DA; Gupta K; Kundu S
Antioxid Redox Signal; 2024 Jun; 40(16-18):1025-1049. PubMed ID: 37975291
[No Abstract] [Full Text] [Related]
11. Treating sickle cell anemia: A new era dawns.
Steinberg MH
Am J Hematol; 2020 Apr; 95(4):338-342. PubMed ID: 31925819
[No Abstract] [Full Text] [Related]
12. Growth differentiation factor-15 in young sickle cell disease patients: relation to hemolysis, iron overload and vascular complications.
Tantawy AA; Adly AA; Ismail EA; Darwish YW; Ali Zedan M
Blood Cells Mol Dis; 2014 Dec; 53(4):189-93. PubMed ID: 25065856
[TBL] [Abstract][Full Text] [Related]
13. The evolving treatment landscape for children with sickle cell disease.
Jacob SA; Talati R; Kanter J
Lancet Child Adolesc Health; 2023 Nov; 7(11):797-808. PubMed ID: 37858508
[TBL] [Abstract][Full Text] [Related]
14. Fertility challenges for women with sickle cell disease.
Ghafuri DL; Stimpson SJ; Day ME; James A; DeBaun MR; Sharma D
Expert Rev Hematol; 2017 Oct; 10(10):891-901. PubMed ID: 28891355
[TBL] [Abstract][Full Text] [Related]
15. Curative approaches for sickle cell disease: A review of allogeneic and autologous strategies.
Bauer DE; Brendel C; Fitzhugh CD
Blood Cells Mol Dis; 2017 Sep; 67():155-168. PubMed ID: 28893518
[TBL] [Abstract][Full Text] [Related]
16. Clinical Features of β-Thalassemia and Sickle Cell Disease.
McGann PT; Nero AC; Ware RE
Adv Exp Med Biol; 2017; 1013():1-26. PubMed ID: 29127675
[TBL] [Abstract][Full Text] [Related]
17. Defining curative endpoints for sickle cell disease in the era of gene therapy and gene editing.
Locatelli F; Corbacioglu S; Hobbs W; Frangoul H; Walters MC
Am J Hematol; 2024 Mar; 99(3):430-438. PubMed ID: 38010293
[TBL] [Abstract][Full Text] [Related]
18. [How I treat ... sickle cell anemia: current therapies].
Rezaei Kalantari H
Rev Med Liege; 2001 Oct; 56(10):671-5. PubMed ID: 11765575
[TBL] [Abstract][Full Text] [Related]
19. Sickle cell disease.
Ware RE; de Montalembert M; Tshilolo L; Abboud MR
Lancet; 2017 Jul; 390(10091):311-323. PubMed ID: 28159390
[TBL] [Abstract][Full Text] [Related]
20. Advances in the diagnosis and treatment of sickle cell disease.
Brandow AM; Liem RI
J Hematol Oncol; 2022 Mar; 15(1):20. PubMed ID: 35241123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
